Skip to main content

Table 1 The IC50 of Ibr-7 and ibrutinib in PANC-1 and Capan2 cells

From: The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR

Cell line Ibrutinib (μmol/L) Ibr-7 (μmol/L)
PANC-1 20.8 1.7
Capan2 29.6 2.5